An update from Respiri Limited ( (AU:RSH) ) is now available.
Respiri Limited has announced that its April 2025 General Meeting will be held virtually on April 16, 2025. Shareholders are encouraged to vote by proxy and can participate in the meeting online, where they will have the opportunity to ask questions and vote on resolutions. This move to a virtual format reflects the company’s adaptation to digital engagement with stakeholders, potentially increasing accessibility and participation.
More about Respiri Limited
Respiri Limited operates in the healthcare industry, focusing on the development and commercialization of innovative respiratory health products. The company is known for its primary product, Wheezo, a device designed to monitor wheezing in asthma patients, which aligns with its market focus on respiratory health management.
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $40.88M
For detailed information about RSH stock, go to TipRanks’ Stock Analysis page.